RELVAR(TM) ELLIPTA(TM) Gains Approval in Japan for the Treatment of Asthma GlaxoSmithKline plc and Theravance, Inc. today announced that the Japanese Ministry of Health, Labour and Welfare has approved RELVAR™ ELLIPTA™ for the treatment of bronchial asthma . Relvar Ellipta is ...
Sept. 20, 2013 - Marketwired via Yahoo! Finance